Mallinckrodt will acquire Sucampo Pharmaceuticals’ commercial and development assets for approximately $1.2 billion, pending regulatory approval.
Recent SEC filings provided insights into Exact Sciences, the company that manufactures Cologuard, finding President and CEO Kevin Conroy sold 245,362 shares for a total of $13 million.
Pentax Medical launched its C.A.P. HD Duodenoscope in the U.S.; it is the first duodenoscope with a disposable distal cap.
More articles on gastroenterology:
Mallinckrodt acquiring Sucampo Pharmaceuticals for $1.2B — 4 insights
Exact Sciences CEO sells $6.5M — Hedge funds hold 84.5% of company: 4 insights
GI leader to know: Dr. Arthur Berman of Florida Center for Gastroenterology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
